Dr. Sarah Naomi Jacobson, MD

Dr. Jacobson practices at Gould Dermatology Group in Menlo Park, California.

Dr. Jacobson's NPI, 1447392493, was assigned on February 13, 2007. Dr. Jacobson graduated from University Of Michigan Medical School in 2002. Dr. Jacobson holds California license A95483.

Dr. Jacobson's primary practice is Gould Dermatology Group, at 695 Oak Grove Ave, Menlo Park, CA 94025 in San Mateo County. The practice phone is (650) 327-5783.

Dr. Jacobson's primary practice is Gould Dermatology Group in Menlo Park, California. Dr. Jacobson is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is Gould Dermatology Group. Dmand AI also links Dr. Jacobson to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jacobson practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Jacobson's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Jacobson is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Jacobson's licenses on file in 3 states: California, Michigan and North Carolina.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, corns and calluses, itchy rashes and rash among the conditions Dr. Jacobson treats.

CMS data shows 3,119 Medicare services from Dr. Jacobson across 12 procedure codes in 2024, for 547 Medicare patients. Medicare paid $187,436 for them. Every service was in an office.

CMS counts 547 Medicare patients who saw Dr. Jacobson in 2024. The largest group is 75 to 84, with 252 patients. 74% of them have high cholesterol, and 55% have high blood pressure. Their average risk score is 0.81, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Jacobson's median patient age at 70, with 62% women.

In 2024, Dr. Jacobson wrote 454 Medicare Part D claims for 200 patients. 97% of them were for generic drugs. CMS names the drug for 338 of them, across 11 drugs with 11 or more claims each, at $8,463 in total drug cost. In 2023, CMS named 343 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Jacobson for performance year 2024, reported individually. Dr. Jacobson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jacobson as offering telehealth. CMS counts 758 procedures of removal of skin lesions by Dr. Jacobson, more than 91% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 13 general payments to Dr. Jacobson from 3 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $234.

Dr. Jacobson graduated from University Of Michigan Medical School in 2002.

Dr. Jacobson is in network with 3 carriers, including Blue Cross Blue Shield of Massachusetts, Regence Health Plans and CMS Medicare. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.